Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (fGF23)-independent mechanism
Academic Article
Publication Date:
2011
CRIS type:
1.1 Articolo in rivista
Keywords:
Antineoplastic Agents; Benzenesulfonates; Fibroblast Growth Factors; Humans; Hypophosphatemia; Kidney Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Pyridines; Hematology; Oncology
List of contributors:
Bellini, E.; Pia, A.; Brizzi, M. P.; Tampellini, M.; Torta, M.; Terzolo, M.; Dogliotti, Luigi; Berruti, Alfredo
Published in: